"Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI."

LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI.

Bone marrow fibrosis may be a late reversible toxicity of high-dose imatinib therapy in chronic myeloid leukemia. Click to show full abstract

Bone marrow fibrosis may be a late reversible toxicity of high-dose imatinib therapy in chronic myeloid leukemia.

Keywords: marrow fibrosis; imatinib therapy; bone marrow

Journal Title: Blood advances
Year Published: 2019

Link to full text (if available)

Share on Social Media: Sign Up to like & get
recommendations!
0

LAUSR

You are not signed in:

Sign Up!

Related content

More Information News Social Media Video Recommended